EUVIMEDEUVIMED entdecken
Open Access

Biosafety in the Time of Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: The Philippine Experience

Michael O Baclig

Applied Biosafety · 01.09.2021 · 26 (S1) · S-10-S-15

DOI: 10.1089/apb.20.0069 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Biosafety, erschienen am 01.09.2021. Verfasst von Michael O Baclig. Beteiligte Einrichtung: Research and Biotechnology Group, Center for Basic Science Research, St. Luke's Medical Center, Quezon City, Philippines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

COVID-19biosafety standardslaboratory assessmentmitigation controlsperformance

Autor:innen und Institutionen

  • Research and Biotechnology Group, Center for Basic Science Research, St. Luke's Medical Center, Quezon City, Philippines.
  • St. Luke's Medical Center College of Medicine-WHQM, Quezon City, Philippines.

Zitieren

APA

Baclig, M. O. (2021). Biosafety in the Time of Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: The Philippine Experience. Applied Biosafety, 26(S1), S-10-S-15. https://doi.org/10.1089/apb.20.0069

Vancouver

Baclig MO. Biosafety in the Time of Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: The Philippine Experience. Applied Biosafety. 2021;26(S1):S-10-S-15. doi:10.1089/apb.20.0069

BibTeX
@article{Baclig2021,
  author = {Baclig, Michael O},
  title = {Biosafety in the Time of Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: The Philippine Experience},
  journal = {Applied Biosafety},
  year = {2021},
  volume = {26},
  number = {S1},
  pages = {S--10--S--15},
  doi = {10.1089/apb.20.0069}
}
Kostenlos starten →